Intracoastal Capital, Llc - Sep 30, 2025 SCHEDULE 13G/A Report for PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share

Filing Manager
INTRACOASTAL CAPITAL, LLC
Reporting Manager
Mitchell P. Kopin
Security
PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share
Shares outstanding
6.96M shares
Disclosed Ownership
696K shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
11/7/2025, 05:29 PM
Date of event
Sep 30, 2025
Previous filing
Jan 15, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Mitchell P. Kopin 9.99% 696K 0 696K /s/ Mitchell P. Kopin Mitchell P. Kopin
Daniel B. Asher 9.99% 687K 82.7K 604K /s/ Daniel B. Asher Daniel B. Asher
Intracoastal Capital LLC 9.99% 696K 0 696K /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager